| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC2869 |
| Trial ID | NCT05155189 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CCAR031 |
| Co-treatment | Lenvatinib/PD-1(L1) monoclonal antibody |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma |
| Year | 2021 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | 0921-028 |
| Cohort 1 | |||||||
|
|||||||